NTRK1 and melanoma: Pathway analysis with the differentially down-regulated phosphor-motifs depicts receptor tyrosine kinases, inflammatory interleukins, ERK1/2, AKT, and mTOR as the major signaling cascades that are affected after treatment of melanoma cells with 3, 3′- (3, 5-DCPBC) for a period of 4 h.